The United States Department of Defense
has awarded a contract worth $US230 million ($302 million) to Brisbane-based
biotech firm Ellume to ramp up production of its COVID-19 home test kits.
The at-home tests are designed to detect
fragments of the virus from a nasal swab.
It can be performed in 15 minutes with results reported via a smartphone
app. The test will be purchased without
a prescription in the US, but not available in Australia.
"It has been a lot of work
from many hundreds of people over a decade, and a terrific
team effort to get to this point…it is very rewarding," Ellume
founder and CEO Dr Sean Parsons told Today.
The company had been working on developing a test for the flu when they changed tact to deal with the coronavirus, he said……
No comments:
Post a Comment